Research and Markets: 2016 Male Infertility-Global API Manufacturers, Marketed and Phase III Drugs Landscape Report

DUBLIN–(BUSINESS WIRE)–Research and Markets (
has announced the addition of the “Male
Infertility-Global API Manufacturers, Marketed and Phase III Drugs
Landscape, 2016”
report to their offering.

This report, Male Infertility-Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2016, provides comprehensive insights about
the marketed drugs, drug sales, Phase III pipeline drugs and their API
Manufacturers across the globe.

The Report provides the historical and forecasted sales of the drugs
till 2018. The Report gives insights into patents providing the patent
protection data and marketing exclusivity of all the drugs across the
Male Infertility.

Key Topics Covered:

  • A snapshot of the global Market and Phase III therapeutics scenario
    for Male Infertility.
  • A review of the marketed products under prescription for Male
    Infertility, regulatory information and marketing status.
  • Coverage of global patent coverage and detailed commentaries on the US
    patent challenges.
  • Graphical representation of investigational products for patent expiry
    and market exclusivities across the globe.
  • Coverage of API Manufacturers for Male Infertility drugs in the United
    States, Europe and Asian Regions with location details.

Benefits of this Report:

  • Evaluate the marketing status and exclusivity details of Male
    Infertility key products to exploit opportunities for generic drug
    development opportunities.
  • Identify and understand important and diverse types of therapeutics
    under Phase III development for Male Infertility.
  • Design effective counter-strategies to gain competitive advantage by
    identifying the key patent expiry details and exclusivity with respect
    to Male Infertility.
  • API intelligence over marketed drugs forMale Infertility and gaining
    primary intelligence over active ingredients manufacturers across the

Report Structure:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Male Infertility

7. Phase III Drugs for Male Infertility

8. Discontinued Drugs for Male Infertility

9. Appendix

10. Methodology

11. Consulting Services

12. Contact Us

13. Disclaimer

For more information visit


Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare
and Medical Devices
, Pharmaceuticals